Gastric Conduit Resection and Jejunal Interposition for Recurrent Esophageal Cancer

• Published in: The Annals of thoracic surgery Vol. 93; no. 5; pp. 1727 - 1729
• Main Authors: van der Sluis, Pieter C., MD, Verhage, Roy J.J., MD, van der Horst, Sylvia, MS, Siersema, Peter D., MD, PhD, Braunius, Weibel W., MD, van Hillegersberg, Richard, MD, PhD
• Format: Journal Article
• Language: English
• Published: New York, NY Elsevier Inc 01.05.2012; Elsevier
• Subjects: Adenocarcinoma - pathology; Adenocarcinoma - therapy; Anastomosis, Surgical; Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy; Biological and medical sciences; Cardiology. Vascular system; Cardiothoracic Surgery; Chemoradiotherapy - methods; Combined Modality Therapy; Esophageal Neoplasms - pathology; Esophageal Neoplasms - therapy; Esophagectomy - methods; Esophagogastric Junction - pathology; Esophagogastric Junction - surgery; Esophagus; Follow-Up Studies; Gastrectomy - methods; Gastroenterology. Liver. Pancreas. Abdomen; Humans; Jejunum - surgery; Laparotomy - methods; Male; Medical sciences; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local - pathology; Neoplasm Recurrence, Local - surgery; Pneumology; Reconstructive Surgical Procedures - methods; Risk Assessment; Stomach - surgery; Surgery; Transplantation, Autologous; Treatment Outcome; Tumors; 7; Stomach; Relapse; Esophageal disease; Surgical resection; Malignant tumor; Recurrent; Esophagus cancer; Jejunum; Treatment; Surgery; Digestive diseases; Anesthesia; Circulatory system; Cardiology; Interposition; Cancer
• ISSN: 0003-4975; 1552-6259
• DOI: 10.1016/j.athoracsur.2011.09.076

We describe the case of a 58-year-old man with recurrent adenocarcinoma at the site of an esophagogastrostomy that we treated by radical surgical resection and jejunal interposition. Oral intake was started on the 6th postoperative day and the patient was discharged on the 11th postoperative day. Seven months after the surgical procedure no signs of tumor recurrence were detected. Resection of localized (recurrent) esophageal cancer may well be a valuable treatment option and is therefore an interesting therapeutic option in patients with recurrent disease. However this needs to be investigated in a randomized controlled trial.